Republic of Moldova
Tuberculosis profile
| High MDR-TB burden |
Population  2012 3.5 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.63 (0.62–0.64) 18 (18–18)
Mortality (HIV+TB only) 0.085 (0.072–0.1) 2.4 (2.1–2.9)
Prevalence  (includes HIV+TB) 8.8 (4.2–15) 249 (120–424)
Incidence  (includes HIV+TB) 5.6 (4.6–6.7) 160 (132–190)
Incidence (HIV+TB only) 0.34 (0.28–0.4) 9.6 (7.9–11)
Case detection, all forms (%) 79 (66–95)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 1 346 (35) Relapse 559 (37)
Smear-negative 1 930 (51) Treatment after failure 171 (11)
Smear-unknown / not done 132 (3) Treatment after default 295 (20)
Extrapulmonary 396 (10) Other 466 (31)
Other 0 (0)      
Total new 3 804   Total retreatment 1 491  
           
Other (history unknown) 46        
Total new and relapse 4 363   Total cases notified 5 341  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 3.3 2.1 1.3
Age < 15 3 17 125
Laboratories 2012
Smear (per 100 000 population) 1.7
Culture (per 5 million population) 5.7
Drug susceptibility testing (per 5 million population) 5.7
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 62   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 79  
Retreatment 38  
TB/HIV 2012 Number (%)
TB patients with known HIV status 5 348 (100)
HIV-positive TB patients 303 (6)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART) 103 (34)
HIV-positive people screened for TB 2 409  
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 24 (21–26) 62 (59–65)
MDR-TB cases among notified pulmonary
TB cases
810 (730–890) 930 (880–980)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 1 264 (67%) 933 (63%) 2 216
Laboratory-confirmed MDR-TB cases 299 581 894
Patients started on MDR-TB treatment     853
Financing TB control 2013
National TB programme budget (US$ millions) 53
% Funded domestically 65%
% Funded internationally 12%
% Unfunded 23%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-24 Data: www.who.int/tb/data